Sevabertinib showed promise in early trials for non-squamous non-small-cell lung cancer with HER2 mutations. Read more at straitstimes.com. Read more at straitstimes.com.
“Reckless” and “dangerous” were just two of the broadsides American medical groups lobbed at Robert F. Kennedy Jr.’s vaccine advisers after they recommended ending universal vaccination at birth for ...
After 17 years of service to his country filled with physical and mental strain, a retired Navy SEAL was contemplating ...